Dexbrompheniramine maleate 0.4 MG/ML / dextromethorphan hydrobromide 3 MG/ML / phenylephri... — RxCUI 1812101
RxNorm drug concept · Semantic clinical drug
RxCUI 1812101
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1812101
Official nameDexbrompheniramine maleate 0.4 MG/ML / dextromethorphan hydrobromide 3 MG/ML / phenylephrine hydrochloride 1.5 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdexbrompheniramine maleate 2 MG / dextromethorphan HBr 15 MG / phenylephrine HCl 7.5 MG per 5 ML Oral Solution; dexbrompheniramine maleate 2 MG / dextromethorphan HBr 15 MG / phenylephrine HCl 7.5 MG in 5 mL Oral Solution
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Phenylephrine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Yes, it's the same active ingredient, but used in very different ways depending on the form. The nasal spray delivers a tiny amount directly to the nasal lining to temporarily shri...
- I see phenylephrine in nasal sprays at the pharmacy AND as an IV drug in the hospital — is it really the same medication?
- You should check with your doctor first. Phenylephrine constricts blood vessels, which can raise blood pressure and put extra strain on the heart — even from a nasal spray. If you...
- Can I use the nasal spray if I have high blood pressure or heart disease?
🕸️ Concept Web — How Dexbrompheniramine maleate 0.4 MG/ML / dextromet... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Dexbrompheniramine maleate 0.4 MG/ML / dextromethorphan hydrobromide 3 MG/ML / phenylephrine hydrochloride 1.5 MG/ML Oral Solution
RxCUI 1812101 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 7
The active substance itself — no strength, form, or brand attached yet.
-
Dexbrompheniramine
22696IN -
Dextromethorphan
3289IN -
Phenylephrine
8163IN -
Dexbrompheniramine / dextromethorphan / phenylephrine
1008349MIN -
Dexbrompheniramine maleate
48936PIN -
Dextromethorphan hydrobromide
102490PIN -
Phenylephrine hydrochloride
8164PIN
-
Dexbrompheniramine
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Dexbrompheniramine / dextromethorphan / phenylephrine Oral Solution
757013SCDF -
Dexbrompheniramine maleate / dextromethorphan hydrobromide / phenylephrine hydrochloride Oral Solution
2645371SCDFP -
Dexbrompheniramine / dextromethorphan / phenylephrine Oral Liquid Product
1157211SCDG -
Dexbrompheniramine / dextromethorphan / phenylephrine Oral Product
1157212SCDG -
Dexbrompheniramine maleate / dextromethorphan hydrobromide / phenylephrine hydrochloride Oral Liquid Product
2660386SCDGP -
Dexbrompheniramine maleate / dextromethorphan hydrobromide / phenylephrine hydrochloride Oral Product
2661153SCDGP -
Oral Solution
316968DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Dexbrompheniramine / dextromethorphan / phenylephrine Oral Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Dexbrompheniramine maleate 0.4 MG/ML
1300163SCDC -
Dextromethorphan hydrobromide 3 MG/ML
1010945SCDC -
Phenylephrine hydrochloride 1.5 MG/ML
996620SCDC
-
Dexbrompheniramine maleate 0.4 MG/ML
Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Dexbrompheniramine maleate 0.4 MG/ML
SCDC · 1300163 -
Dextromethorphan hydrobromide 3 MG/ML
SCDC · 1010945 -
Phenylephrine hydrochloride 1.5 MG/ML
SCDC · 996620 -
Dexbrompheniramine / dextromethorphan / phenylephrine Oral Solution
SCDF · 757013 -
Dexbrompheniramine maleate / dextromethorphan hydrobromide / phenylephrine hydrochloride Oral Solution
SCDFP · 2645371 -
Dexbrompheniramine / dextromethorphan / phenylephrine Oral Liquid Product
SCDG · 1157211 -
Dexbrompheniramine / dextromethorphan / phenylephrine Oral Product
SCDG · 1157212 -
Dexbrompheniramine maleate / dextromethorphan hydrobromide / phenylephrine hydrochloride Oral Liquid Product
SCDGP · 2660386 -
Dexbrompheniramine maleate / dextromethorphan hydrobromide / phenylephrine hydrochloride Oral Product
SCDGP · 2661153
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 1812101 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 69367-0353-16 | 473 mL in 1 BOTTLE (69367-353-16) | WesTussin DM NF | Westminster Pharmaceuticals, LLC | 2023-07-19 |
Observed labelers:
Westminster Pharmaceuticals, LLC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.0463
Range $0.0463–$0.0463
· middle 50% $0.0463–$0.0463
· 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.